Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' RITZ J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 163 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Soiffer, RJ; Weller, E; Alyea, EP; Mauch, P; Webb, IL; Fisher, DC; Freedman, AS; Schlossman, RL; Gribben, J; Lee, S; Anderson, KC; Marcus, K; Stone, RM; Antin, JH; Ritz, J
      CD6+donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors

      JOURNAL OF CLINICAL ONCOLOGY
    2. Mahajan, S; Gollob, JA; Ritz, J; Frank, DA
      CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells

      EXPERIMENTAL HEMATOLOGY
    3. Zorn, E; Orsini, E; Wu, CJ; Stein, B; Chillemi, A; Canning, C; Alyea, EP; Soiffer, RJ; Ritz, J
      A CD4+T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cells

      TRANSPLANTATION
    4. Yang, XF; Wu, CJ; McLaughlin, S; Chillemi, A; Wang, KS; Canning, C; Alyea, EP; Kantoff, P; Soiffer, RJ; Dranoff, G; Ritz, J
      CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    5. Alyea, E; Weller, E; Schlossman, R; Canning, C; Webb, I; Doss, D; Mauch, P; Marcus, K; Fisher, D; Freeman, A; Parikh, B; Gribben, J; Soiffer, R; Ritz, J; Anderson, K
      T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect

      BLOOD
    6. Hochberg, EP; Chillemi, AC; Wu, CJ; Neuberg, D; Canning, C; Hartman, K; Alyea, EP; Soiffer, RJ; Kalams, SA; Ritz, J
      Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults

      BLOOD
    7. Wang, KS; Zorn, E; Ritz, J
      Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation

      BLOOD
    8. Orsini, E; Alyea, EP; Chillemi, A; Schlossman, R; McLaughlin, S; Canning, C; Soiffer, RJ; Anderson, KC; Ritz, J
      Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    9. Orsini, E; Alyea, EP; Schlossman, R; Canning, C; Soiffer, RJ; Chillemi, A; Neuberg, D; Anderson, KC; Ritz, J
      Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion

      BONE MARROW TRANSPLANTATION
    10. Wu, CJ; Yang, XF; McLaughlin, S; Neuberg, D; Canning, C; Stein, B; Alyea, EP; Soiffer, RJ; Dranoff, G; Ritz, J
      Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia

      JOURNAL OF CLINICAL INVESTIGATION
    11. Wang, KS; Frank, DA; Ritz, J
      Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4

      BLOOD
    12. Wu, CJ; Chillemi, A; Alyea, EP; Orsini, E; Neuberg, D; Soiffer, RJ; Ritz, J
      Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism

      BLOOD
    13. Oakes, D; Ritz, J
      Regression in a bivariate copula model

      BIOMETRIKA
    14. Frank, DA; Mahajan, S; Ritz, J
      Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling

      NATURE MEDICINE
    15. Robertson, MJ; Cameron, C; Atkins, MB; Gordon, MS; Lotze, MT; Sherman, ML; Ritz, J
      Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer

      CLINICAL CANCER RESEARCH
    16. Dahia, PLM; Aguiar, RCT; Alberta, J; Kum, JB; Caron, S; Sill, H; Marsh, DJ; Ritz, J; Freedman, A; Stiles, C; Eng, C
      PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies

      HUMAN MOLECULAR GENETICS
    17. Sehn, LH; Alyea, EP; Weller, E; Canning, C; Lee, S; Ritz, J; Antin, JH; Soiffer, RJ
      Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneicbone marrow transplantation for chronic myelogenous leukemia: Impact of donor lymphocyte infusion

      JOURNAL OF CLINICAL ONCOLOGY
    18. Friedberg, JW; Neuberg, D; Stone, RM; Alyea, E; Jallow, H; LaCasce, A; Mauch, PM; Gribben, JG; Ritz, J; Nadler, LM; Soiffer, RJ; Freedman, AS
      Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma

      JOURNAL OF CLINICAL ONCOLOGY
    19. Germer, CT; Albrecht, D; Isbert, C; Ritz, J; Roggan, A; Buhr, HJ
      Diffusing fibre tip for the minimally invasive treatment of liver tumours by interstitial laser coagulation (ILC): An experimental ex vivo study

      LASERS IN MEDICAL SCIENCE
    20. Gollob, JA; Schnipper, CP; Murphy, EA; Ritz, J; Frank, DA
      The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation

      JOURNAL OF IMMUNOLOGY
    21. Wang, KS; Ritz, J; Frank, DA
      IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells

      JOURNAL OF IMMUNOLOGY
    22. Borrego, F; Robertson, MJ; Ritz, J; Pena, J; Solana, R
      CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor

      IMMUNOLOGY
    23. Freedman, AS; Neuberg, D; Mauch, P; Soiffer, RJ; Anderson, KC; Fisher, DC; Schlossman, R; Alyea, EP; Takvorian, T; Jallow, H; Kuhlman, C; Ritz, J; Nader, LM; Gribben, JG
      Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma

      BLOOD
    24. BREITWEG J; DERRICK M; KRAKAUER D; MAGILL S; MIKUNAS T; MUSGRAVE B; REPOND J; STANEK R; TALAGA RL; YOSHIDA R; ZHANG H; MATTINGLY MCK; ANSELMO F; ANTONIOLI P; BARI G; BASILE M; BELLAGAMBA L; BOSCHERINI D; BRUNI A; BRUNI G; ROMEO GC; CASTELLINI G; CIFARELLI L; CINDOLO F; CONTIN A; COPPOLA N; CORRADI M; DEPASQUALE S; GIUSTI P; IACOBUCCI G; LAURENTI G; LEVI G; MARGOTTI A; MASSAM T; NANIA R; PALMONARI F; PESCI A; POLINI A; SATORELLI G; GARCIA YZ; ZICHICHI A; AMELUNG C; BORNHEIM A; BROCK I; COBOKEN E; CRITTENDEN J; DEFFNER R; ECKERT M; GROTHE M; HARTMANN H; HEINLOTH K; HEINZ L; HILGER E; JAKOB HP; KAPPES A; KATZ UF; KERGER R; PAUL E; PFEIFFER M; STAMM J; WIEBER H; BAILEY DS; CAMPBELLROBSON S; COTTINGHAM WN; FOSTER B; HALLWILTON R; HEATH GP; HEATH HF; MCFALL JD; PICCIONI D; ROFF DG; TAPPER RJ; AYAD R; CAPUA M; IANNOTTI L; SCHIOPPA M; SUSINNO G; KIM JY; LEE JH; LIM LT; PAC MY; CALDWELL A; CARTIGLIA N; JING Z; LIU W; MELLADO B; PARSONS JA; RITZ J; SAMPSON S; SCIULLI F; STRAUB PB; ZHU Q; BORZEMSKI P; CHWASTOWSKI J; ESKREYS A; FIGIEL J; KLIMEK K; PRZYBYCIEN MB; ZAMIEJSKI L; ADAMCZYK L; BEDAAREK B; BUKOWY M; CZERMAK AM; JELEN K; KISIELEWSKA D; KOWALSKI T; PRZYBYCIEN M; RULIKOWSKAZAREBSKA E; SUSZYCKI L; ZAJAC J; DULINSKI Z; KOTANSKII A; ABBIENDI G; BAUERDICK LAT; BEHRENS U; BEIER H; BIENLEIN JK; DESLER K; DREWS G; FRICKE U; GIALAS I; GOEBEL F; GOTTLICHER P; GRACIANI R; HAAS T; HAIN W; HASELL D; HEBBEL E; JOHNSON KF; KASEMANN M; KOCH W; KOTZ U; KOWALSKI H; LINDEMANN L; LOHR B; MILEWSKI J; MILITE M; MONTEIRO T; NG JST; NOTZ D; PARK IH; PELLEGRINO A; PELUCCHI F; PIOTRZKOWSKI K; ROHDE M; ROLDAN J; RYAN JJ; SAVIN AA; SCHNEEKLOTH U; SCHWARZER O; SELONKE F; STONJEK S; SURROW B; TASSI E; WESTPHAL D; WOLF G; WOLLMER U; YOUNGMAN C; ZEUNER W; BUROW BD; COLDEWEY C; GRABOSCH HJ; MEYER A; SCHLENSTEDT S; BARBAGLI G; GALLO E; PELFER P; MACCARRONE G; VOTANO L; BAMBERGER A; EISENHARDT S; MARKUN P; RAACH H; TREFZGER T; WOLFLE S; BROMLEY JT; BROOK NH; BUSSEY PJ; DOYLE AT; MACDONALD N; SAXON DH; SINCLAIR LE; SKILLICORN IO; STRICKLAND E; WAUGH R; BOHNET I; GENDNER N; HOLM U; MEYERLARSEN A; SALEHI H; WICK K; GARFAGNINI A; GLADILIN LK; HORSTMANN D; KCIRA D; KLANNER R; LOHRMANN E; POELZ G; SCHOTT W; ZETSCHE F; BACON TC; BUTTERWORTH I; COLE JE; HOWELL G; LAMBERTI L; LONG KR; MILLER DB; PAVEL N; PRINIAS A; SEDGBEER JK; SIDERIS D; WALKER R; MALLIK T; WANG SM; WU JT; CLOTH P; FILGES D; FLECK JI; ISHII T; KUZE M; SUZUKI I; TOKUSHUKU K; YAMADA S; YAQMAUCHI K; YAMAZAKI Y; HONG SJ; LEE SB; NAM SW; PARK SK; BARREIRO F; FERNANDEZ JP; GARCIA G; GLASMAN C; HERNANDEZ JM; HERVAS L; LABARGA L; MARTINEZ M; DELPESO J; PUGA J; TERRON J; DETROCONIZ JF; CORRIVEAU F; HANNA DS; HARTMAAN J; HUNG LW; MURRAY WN; OCHS A; RIVELINE M; STAIRS DG; STLAURENT M; ULLMANN R; TSURUGAI T; BASHKIROV V; DOLGOSHEIN BA; STIFUTKIN A; BASHINDZHAGYAN GL; ERMOLOV PF; GOLUBKOV YA; KHEIN LA; KOROTKOVA NA; KORZHAVINA IA; KUZMIN VA; LUKINA OY; PROSKURYAKOV AS; SHCHEGLOVA LM; SOLOMIN AN; ZOTKIN SA; BOKEL C; BOTJE M; BRUMMER N; ENGELEN J; KOFFEMAN E; KOOIJMAN P; VANSIGHEM A; TIECKE E; TUNING N; VERKERKE W; VOSSEBELD J; WIGGERS L; DEWOLF E; ACOSTA D; BYLSMA B; DURKIN LS; GILMORE J; GINSBURG CM; KIM CL; LING TY; NYLANDER P; ROMANOWSKI TA; BLAIKLEY HE; CASHMORE RJ; COOPERSARKAR AM; DEVENISH RCE; EDMONDS JK; GROSSEKNETTER J; HARNEW N; NATH C; NOYES VA; QUADT A; RUSKE O; TICKNER JR; WALCZAK R; WATERS DS; BERTOLIN A; BRUGNERA R; CARLIN R; DALCORSO F; DOSSELLI U; LIMENTANI S; MORANDIN M; POSOCCO M; STANCO L; STROILI R; VOCI C; BULMAHN J; OH BY; OKRASINSKI JR; TOOTHACKER WS; WHITMORE JJ; DAGOSTINI G; MARINI G; NIGRO A; RASO M; HART JC; MCCUBBIN NA; SHAH TP; EPPERSON D; HEUSCH C; RAHN JT; SADROZINSKI HFW; SEIDEN A; WICHMANN R; WILLIAMS DC; ABRAMOWICZ H; BRISKIN G; DAGAN S; KANANOV S; LEVY A; ABE T; FUSAYASU T; INUZUKA M; NAGANO K; UMEMORI K; YAMASHITA T; HAMATSU R; HIROSE T; HOMMA K; KITAMURA S; MATSUSHITA T; ARNEODO T; CIRIO R; COSTA M; FERRERO MI; MASELLI S; MONACO V; PERONI C; PETRUCCI TC; RUSPA M; SACCHI R; SOLANO A; STAIANO A; DARDO M; BAILEY DC; FAGERSTROEM CP; GALEA R; HARTNER GF; JOE KK; LEVMAN GM; MARTIN JF; ORR RS; POLENZ S; SABETFAKHRI A; SIMMONS D; TEUSCHER RJ; BUTTERWORTH JM; CATTERALL CD; HAYES ME; JONES TW; LANE JB; SAUNDERS RL; SUTTON MR; WING M; CIBOROWSKI J; GRZELAK G; KASPRZAK M; NOWAK RJ; PAWLAK JM; PAYLAK R; TYMIENIECKA T; WROBLEWSKI AK; ZAKRZEWSKI JA; ZARNECKI AF; ADAMUS M; DEPPE O; EISENBERG Y; HOCHMAN D; KARSHON U; BADGETT WF; CHAPIN D; CROSS R; DASU S; FOUDAS C; LOVELESS RJ; MATTINGLY S; REEDER DD; SMITH WH; VAICIULIS A; WODARCZYK M; DESHPANDE A; DHAWAN S; HUGHES VW; BHADRA S; FRISKEN WR; KHAKZAD M; SCHMIDKE WB
      DIFFRACTIVE DIJET CROSS-SECTIONS IN PHOTOPRODUCTION AT HERA

      EUROPEAN PHYSICAL JOURNAL C-PARTICLES AND FIELDS
    25. BANI L; DAVID D; FEVRIER M; MOREAU JL; CAYOTA A; NAKARAI T; SUGAMURA K; RITZ J; THEZE J
      INTERLEUKIN-2 GAMMA-CHAIN - INTRACELLULAR EXPRESSION ON RESTING CD4 T-CELLS AND DYSREGULATION BY HIV-1 GP120 IN ACTIVATED CD4 T-LYMPHOCYTES

      European cytokine network
    26. DAVID D; BANI L; MOREAU JL; TREILHOU MP; NAKARAI T; JOUSSEMET M; RITZ J; DUPONT B; PIALOUX G; THEZE J
      IMPACT OF TRIPLE COMBINATION THERAPY ON THE IL-2 REACTIVITY OF CD4 AND CD8 T-LYMPHOCYTES FROM HIV-INFECTED PATIENTS

      European cytokine network
    27. DAVID D; BANI L; MOREAU JL; TREILHOU MP; DEMAISON C; SUN K; FEVRIER M; SALVUCCI O; CAYOTA A; NAKARAI T; CHOUAIB S; DEMONTALEMBERT M; JOUSSEMET M; SUGAMURA K; RITZ J; DUPONT B; PIALOUX G; THEZE J
      DYSREGULATION OF INTERLEUKIN-2 RECEPTOR-BETA AND INTERLEUKIN-2 RECEPTOR-GAMMA EXPRESSION DURING HIV INFECTION

      European cytokine network
    28. BARZEGAR C; MEAZZA R; PERENO R; POTTINCLEMENCEAU C; SCUDELETTI M; BROUTYBOYE D; DOUCET C; TAOUFIK Y; RITZ J; MUSSELLI C; MISHAL Z; JASMIN C; INDIVERI F; FERRINI S; AZZARONE B
      IL-15 IS PRODUCED BY A SUBSET OF HUMAN MELANOMAS, AND IS INVOLVED IN THE REGULATION OF MARKERS OF MELANOMA PROGRESSION THROUGH JUXTACRINE LOOPS

      Oncogene
    29. FREEDMAN AS; NEUBERG D; GRIBBEN JG; MAUCH P; SOIFFER RJ; FISHER DC; ANDERSON KC; ANDERSEN N; SCHLOSSMAN R; KROON M; RITZ J; ASTER J; NADLER LM
      HIGH-DOSE CHEMORADIOTHERAPY AND ANTI-B-CELL MONOCLONAL-ANTIBODY PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN MANTLE-CELL LYMPHOMA - NO EVIDENCE FOR LONG-TERM REMISSION

      Journal of clinical oncology
    30. SOIFFER RJ; FREEDMAN AS; NEUBERG D; FISHER DC; ALYEA EP; GRIBBEN J; SCHLOSSMAN RL; BARTLETTPANDITE L; KUHLMAN C; MURRAY C; FREEMAN A; MAUCH P; ANDERSON KC; NADLER LM; RITZ J
      CD6(-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA() T)

      Bone marrow transplantation
    31. WEBB IJ; JIROUTEK M; COHEN CA; SCHOTT DM; DOSS D; FREEMAN A; RITZ J; SCHLOSSMAN RL; ANDERSON KC
      HIGH LEUKAPHERESIS COMPONENT CD34+ CELL PURITY IMPROVES CD34+ CELL PURITY FOLLOWING CD34+ CELL SELECTION

      Transfusion
    32. DAVID D; BANI L; MOREAU JL; TREILHOU MP; NAKARAI T; JOUSSEMET M; RITZ J; DUPONT B; PIALOUX G; THEZE J
      REGULATORY DYSFUNCTION OF THE INTERLEUKIN-2 RECEPTOR DURING HIV-INFECTION AND THE IMPACT OF TRIPLE COMBINATION THERAPY

      Proceedings of the National Academy of Sciences of the United Statesof America
    33. VOSS SD; DALEY J; RITZ J; ROBERTSON MJ
      PARTICIPATION OF THE CD94 RECEPTOR COMPLEX IN COSTIMULATION OF HUMAN NATURAL-KILLER-CELLS

      The Journal of immunology
    34. GOLLOB JA; SCHNIPPER CP; ORSINI E; MURPHY E; DALEY JF; LAZO SB; FRANK DA; NEUBERG D; RITZ J
      CHARACTERIZATION OF A NOVEL SUBSET OF CD8(-CELLS THAT EXPANDS IN PATIENTS RECEIVING INTERLEUKIN-12() T)

      The Journal of clinical investigation
    35. DELABESSE E; BERNARD M; MEYER V; SMIT L; PULFORD K; CAYUELA JM; RITZ J; BOURQUELOT P; STROMINGER JL; VALENSI F; MACINTYRE EA
      TAL1 EXPRESSION DOES NOT OCCUR IN THE MAJORITY OF T-ALL BLASTS

      British Journal of Haematology
    36. LEE SJ; WELLER E; ALYEA EP; RITZ J; SOIFFER RJ; SOIFFER J
      EFFICACY AND COSTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN ALLOGENEIC T-CELL DEPLETED BONE-MARROW TRANSPLANTATION

      Blood
    37. GOLLOB JA; MURPHY EA; MAHAJAN S; SCHNIPPER CP; RITZ J; FRANK DA
      ALTERED INTERLEUKIN-12 RESPONSIVENESS IN TH1 AND TH2 CELLS IS ASSOCIATED WITH THE DIFFERENTIAL ACTIVATION OF STAT5 AND STAT1

      Blood
    38. DAVID D; BANI L; MOREAU JL; DEMAISON C; SUN K; SALVUCCI O; NAKARAI T; DEMONTALEMBERT M; CHOUAIB S; JOUSSEMET M; RITZ J; THEZE J
      FURTHER ANALYSIS OF INTERLEUKIN-2 RECEPTOR SUBUNIT EXPRESSION ON THE DIFFERENT HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL SUBSETS

      Blood
    39. ALYEA EP; SOIFFER RJ; CANNING C; NEUBERG D; SCHLOSSMAN R; PICKETT C; COLLINS H; WANG YL; ANDERSON KC; RITZ J
      TOXICITY AND EFFICACY OF DEFINED DOSES OF CD4(-MARROW TRANSPLANT() DONOR LYMPHOCYTES FOR TREATMENT OF RELAPSE AFTER ALLOGENEIC BONE)

      Blood
    40. ATKINS MB; ROBERTSON MJ; GORDON M; LOTZE MT; DECOSTE M; DUBOIS JS; RITZ J; SANDLER AB; EDINGTON HD; GARZONE PD; MIER JW; CANNING CM; BATTIATO L; TAHARA H; SHERMAN ML
      PHASE-I EVALUATION OF INTRAVENOUS RECOMBINANT HUMAN INTERLEUKIN-12 INPATIENTS WITH ADVANCED MALIGNANCIES

      Clinical cancer research
    41. SOIFFER RJ; CHAPMAN PB; MURRAY C; WILLIAMS L; UNGER P; COLLINS H; HOUGHTON AN; RITZ J
      ADMINISTRATION OF R24 MONOCLONAL-ANTIBODY AND LOW-DOSE INTERLEUKIN-2 FOR MALIGNANT-MELANOMA

      Clinical cancer research
    42. ROBERTSON MJ; CAMERON C; LAZO S; COCHRAN KJ; VOSS SD; RITZ J
      COSTIMULATION OF HUMAN NATURAL-KILLER-CELL PROLIFERATION - ROLE OF ACCESSORY CYTOKINES AND CELL CONTACT-DEPENDENT SIGNALS

      Natural immunity
    43. BANI L; DAVID D; MOREAU JL; CAYOTA A; NAKARAI T; RITZ J; THEZE J
      EXPRESSION OF THE IL-2 RECEPTOR-GAMMA SUBUNIT IN RESTING HUMAN CD4 T-LYMPHOCYTES - MESSENGER-RNA IS CONSTITUTIVELY TRANSCRIBED AND THE PROTEIN STORED AS AN INTRACELLULAR COMPONENT

      International immunology
    44. LYNCH TJ; LAMBERT JM; CORAL F; SHEFNER J; WEN P; BLATTLER WA; COLLINSON AR; ARINIELLO PD; BRAMAN G; COOK S; ESSELTINE D; ELIAS A; SKARIN A; RITZ J
      IMMUNOTOXIN THERAPY OF SMALL-CELL LUNG-CANCER - A PHASE-I STUDY OF N901-BLOCKED RICIN

      Journal of clinical oncology
    45. THEZE J; BANI L; DAVID D; MOREAU JL; CAYOTA A; NAKARAI T; RITZ J
      EXPRESSION OF THE IL-2 RECEPTOR-GAMMA SUBUNIT IN HUMAN CD4 T-LYMPHOCYTES

      Journal of allergy and clinical immunology
    46. KOLENKO V; WANG Q; RIEDY MC; OSHEA J; RITZ J; CATHCART MK; RAYMAN P; TUBBS R; EDINGER M; NOVICK A; BUKOWSKI R; FINKE J
      TUMOR-INDUCED SUPPRESSION OF T-LYMPHOCYTE PROLIFERATION COINCIDES WITH INHIBITION OF JAK3 EXPRESSION AND IL-2 RECEPTOR SIGNALING - ROLE OF SOLUBLE PRODUCTS FROM HUMAN RENAL-CELL CARCINOMAS

      The Journal of immunology
    47. IDA H; ROBERTSON MJ; VOSS S; RITZ J; ANDERSON P
      CD94 LIGATION INDUCES APOPTOSIS IN A SUBSET OF IL-2-STIMULATED NK CELLS

      The Journal of immunology
    48. CLARET EJ; ALYEA EP; ORSINI E; PICKETT CC; COLLINS H; WANG YL; NEUBERG D; SOIFFER RJ; RITZ J
      CHARACTERIZATION OF T-CELL REPERTOIRE IN PATIENTS WITH GRAFT-VERSUS-LEUKEMIA AFTER DONOR LYMPHOCYTE INFUSION

      The Journal of clinical investigation
    49. FRANK DA; MAHAJAN S; RITZ J
      B-LYMPHOCYTES FROM PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA CONTAINSIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT)1 AND STAT3 CONSTITUTIVELY PHOSPHORYLATED ON SERINE RESIDUES

      The Journal of clinical investigation
    50. GOLLOB JA; KAWASAKI H; RITZ J
      INTERFERON-GAMMA AND INTERLEUKIN-4 REGULATE T-CELL INTERLEUKIN-12 RESPONSIVENESS THROUGH THE DIFFERENTIAL MODULATION OF HIGH-AFFINITY INTERLEUKIN-12 RECEPTOR EXPRESSION

      European Journal of Immunology
    51. WANG DK; FREEMAN GJ; LEVINE H; RITZ J; ROBERTSON MJ
      ROLE OF THE CD40 AND CD95 (APO-1 FAS) ANTIGENS IN THE APOPTOSIS OF HUMAN B-CELL MALIGNANCIES/

      British Journal of Haematology
    52. WEISDORF DJ; BILLETT AL; HANNAN P; RITZ J; SALLAN SE; STEINBUCH M; RAMSAY NKC
      AUTOLOGOUS VERSUS UNRELATED DONOR ALLOGENEIC MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA

      Blood
    53. FREEDMAN A; NEUBERG D; MAUCH P; GRIBBEN J; SOIFFER R; ANDERSON K; ROBERTSON M; FISHER DC; SCHLOSSMAN R; KROON M; RHUDA C; KUHLMAN C; RITZ J; NADLER L
      CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE DOSE INTENSIFICATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR MARKEDLY DEPLETES STEM-CELL RESERVE FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Blood
    54. SCHLOSSMAN RL; WEBB I; ALYEA EP; SOIFFER RJ; FISHER D; VANCE E; GRIBBEN J; FREEDMAN A; NADLER L; RITZ J; ANDERSON KC
      SIMILAR DISEASE-FREE SURVIVAL (DFS) AFTER ALLOGRAFTING AND AUTOGRAFTING FOR MULTIPLE-MYELOMA (MM)

      Blood
    55. SEHN LH; ANTIN JH; WELLER E; ALYEA EP; CANNING C; RITZ J; SOIFFER RJ
      OUTCOME FOLLOWING T-CELL DEPLETED (TCD) VERSUS NON-T-CELL DEPLETED (NON-TCD) ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) - IMPACT OF DONOR LYMPHOCYTE INFUSIONS (DLI)

      Blood
    56. SOIFFER RJ; MAUCH P; NEUBERG D; ALYEA E; FISHER D; SCHLOSSMAN R; GRIBBEN J; VANCE E; FREEDMAN A; ANDERSON K; KUHLMAN C; MARCUS K; NADLER L; RITZ J
      DOSE-ESCALATION OF TOTAL-BODY IRRADIATION (TBI) IN RECIPIENTS OF CD6 DEPLETED ALLOGENEIC BONE-MARROW - TOXICITY AND ANTITUMOR EFFECTS

      Blood
    57. ROBERTSON MJ; CAMERON C; ATKINS MB; GORDON MS; LOTZE MT; SHERMAN ML; RITZ J
      IMMUNOLOGICAL EFFECTS OF INTERLEUKIN-12 ADMINISTERED BY BOLUS INTRAVENOUS-INJECTION TO PATIENTS WITH ADVANCED CANCER

      Blood
    58. LEE SJ; WELLER E; ALYEA EP; RITZ J; SOIFFER RJ
      GRANULOCYTE-COLONY-STIMULATING FACTOR (GCSF) AFTER T-CELL DEPICTED (TCD) ALLOGENEIC TRANSPLANTATION (ALLOBMT) - EFFICACY AND COSTS

      Blood
    59. VOSS SD; RITZ J; ROBERTSON MJ
      PARTICIPATION OF THE CD94 NKG2 RECEPTOR COMPLEX IN COSTIMULATION OF HUMAN NATURAL-KILLER-CELLS/

      Blood
    60. ERNST TJ; VANCE E; ALYEA E; SOIFFER R; QUARTULLI M; RITZ J
      HOMOHARRINGTONINE AND LOW-DOSE ARA-C IS A HIGHLY EFFECTIVE COMBINATION FOR THE TREATMENT OF CML IN CHRONIC PHASE

      Blood
    61. VANCE EA; RITZ J; SOIFFER R
      CMV INFECTION AND DISEASE FOLLOWING T-CELL DEPLETED ALLOGENEIC BMT - THE INFLUENCE OF SEROLOGIC STATUS

      Blood
    62. ALYEA EP; CANNING C; SOIFFER RJ; RITZ J
      PROLONGED TIME TO CYTOGENETIC AND MOLECULAR RESPONSE IN PATIENTS WITHRELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER DONOR LYMPHOCYTE INFUSION (DLI)

      Blood
    63. ORSINI E; ALYEA EP; SCHLOSSMAN R; SOIFFER RJ; ANDERSON KC; RITZ J
      EXPANSION OF PREEXISTING CLONAL POPULATIONS FOLLOWING DONOR LYMPHOCYTE INFUSION FOR RELAPSED MULTIPLE-MYELOMA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    64. ALYEA EP; CHILLEMI A; CANNING C; SOIFFER RJ; RITZ J
      ALLOGENEIC GRAFT-VERSUS-LEUKEMIA IS DIRECTED AGAINST HOST HEMATOPOIETIC ANTIGENS AND IS NOT LEUKEMIA SPECIFIC AS DETERMINED BY CYTOGENETIC AND MOLECULAR ANALYSIS IN PATIENTS WITH CML FOLLOWING DONOR LYMPHOCYTEINFUSION

      Blood
    65. SATO T; OHASHI Y; TACHIBANA K; SOIFFER RJ; RITZ J; MORIMOTO C
      ALTERED TYROSINE PHOSPHORYLATION VIA THE VERY LATE ANTIGEN (VLA) BETA-1 INTEGRIN STIMULATION IS ASSOCIATED WITH IMPAIRED T-CELL SIGNALING THROUGH VLA-4 AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION/

      Blood
    66. SOIFFER RJ; FAIRCLOUGH D; ROBERTSON M; ALYEA E; ANDERSON K; FREEDMAN A; BARTLETTPANDITE L; FISHER D; SCHLOSSMAN RL; STONE R; MURRAY C; FREEMAN A; MARCUS K; MAUCH P; NADLER L; RITZ J
      CD6-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA IN FIRST COMPLETE REMISSION

      Blood
    67. SOIFFER RJ; MURRAY C; SHAPIRO C; COLLINS H; CHARTIER S; LAZO S; RITZ J
      EXPANSION AND MANIPULATION OF NATURAL-KILLER-CELLS IN PATIENTS WITH METASTATIC CANCER BY LOW-DOSE CONTINUOUS-INFUSION AND INTERMITTENT BOLUS ADMINISTRATION OF INTERLEUKIN-2

      Clinical cancer research
    68. BANI L; MOREAU JL; DAVID D; DEMAISON C; SUN K; NAKARAI T; SALUUCCI O; CHOUAIB S; RITZ J; THEZE J
      EVIDENCE FOR DIFFERENTIAL EXPRESSION OF THE BETA-SUBUNITS AND GAMMA-SUBUNITS OF THE IL-2 RECEPTOR IN HUMAN LYMPHOMONONUCLEAR CELLS

      The FASEB journal
    69. ROBERTSON MJ; COCHRAN KJ; CAMERON C; LE JM; TANTRAVAHI R; RITZ J
      CHARACTERIZATION OF A CELL-LINE, NKL, DERIVED FROM AN AGGRESSIVE HUMAN NATURAL-KILLER-CELL LEUKEMIA

      Experimental hematology
    70. VANCE EA; SOIFFER RJ; MCDONALD GB; MYERSON D; FINGEROTH J; RITZ J
      PREVENTION OF TRANSMISSION OF HEPATITIS-G VIRUS IN BONE-MARROW TRANSPLANTATION BY TREATING THE DONOR WITH ALPHA-INTERFERON

      Transplantation
    71. WEBB IJ; CORAL FS; ANDERSEN JW; ELIAS AD; FINBERG RW; NADLER LM; RITZ J; ANDERSON KC
      SOURCES AND SEQUELAE OF BACTERIAL-CONTAMINATION OF HEMATOPOIETIC STEM-CELL COMPONENTS - IMPLICATIONS FOR THE SAFETY OF HEMATOTHERAPY AND GRAFT ENGINEERING

      Transfusion
    72. GOLLOB JA; LI J; KAWASAKI H; DALEY JF; GROVES C; REINHERZ EL; RITZ J
      MOLECULAR INTERACTION BETWEEN CD58 AND CD2 COUNTER-RECEPTORS MEDIATESTHE ABILITY OF MONOCYTES TO AUGMENT T-CELL ACTIVATION BY IL-12

      The Journal of immunology
    73. TAPLIN ME; FRANTZ ME; CANNING C; RITZ J; BLUMBERG RS; BALK SP
      EVIDENCE AGAINST T-CELL DEVELOPMENT IN THE ADULT HUMAN INTESTINAL-MUCOSA BASED UPON LACK OF TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE EXPRESSION

      Immunology
    74. BOUSSIOTIS VA; PARDO NA; COLLINS H; HOUGHTON A; RITZ J; NADLER LM; SOIFFER RJ
      R24 ANTI-GD3 GANGLIOSIDE ANTIBODY CAN INDUCE CO-STIMULATION AND PREVENT THE INDUCTION OF ALLOANTIGEN-SPECIFIC T-CELL CLONAL ANERGY

      European Journal of Immunology
    75. FREEDMAN AS; GRIBBEN JG; NEUBERG D; MAUCH P; SOIFFER RJ; ANDERSON KC; PANDITE L; ROBERTSON MJ; KROON M; RITZ J; NADLER LM
      HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH FOLLICULAR LYMPHOMA DURING FIRST REMISSION

      Blood
    76. PROVAN D; BARTLETTPANDITE L; ZWICKY C; NEUBERG D; MADDOCKS A; CORRADINI P; SOIFFER R; RITZ J; NADLER LM; GRIBBEN JG
      ERADICATION OF POLYMERASE CHAIN REACTION-DETECTABLE CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS IS ASSOCIATED WITH IMPROVED OUTCOME AFTER BONE-MARROW TRANSPLANTATION

      Blood
    77. PIGNATA C; SANGHERA JS; SOIFFER RJ; CHARTIER S; EDER M; PELECH SL; RITZ J
      DEFECTIVE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    78. MCLEAN TW; RINGOLD S; NEUBERG D; STEGMAIER K; TANTRAVAHI R; RITZ J; KOEFFLER HP; TAKEUCHI S; JANSSEN JWG; SERIU T; BARTRAM CR; SALLAN SE; GILLILAND DG; GOLUB TR
      TEL AML-1 DIMERIZES AND IS ASSOCIATED WITH A FAVORABLE OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA/

      Blood
    79. ORSINI E; CLARET EJ; ALYEA EP; SCHLOSSMAN R; CANNING C; SOIFFER RJ; ANDERSON KC; RITZ J
      DISTINCT CHANGES IN T-CELL REPERTOIRE ASSOCIATED WITH GVL AND GVHD INPATIENTS RECEIVING DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    80. ALYEA EP; SCHLOSSMAN RL; CANNING C; COLLINS H; PICKETT C; WANG Y; SOIFFER RJ; ANDERSON KC; RITZ J
      CD8-DEPLETED DONOR LYMPHOCYTE INFUSIONS MEDIATE GRAFT VERSUS MULTIPLE-MYELOMA (MM) EFFECT

      Blood
    81. VANCE EU; FLEMING M; RITZ J; SOIFFER RJ
      OUTCOME OF LYMPHOPROLIFERATIVE DISEASE FOLLOWING CD6 T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    82. GOLLOB JA; MAHAJAN S; RUDDERS SA; RITZ J; FRANK DA
      IFN-GAMMA AND IL-4 PROMOTE TH1 AND TH2 DEVELOPMENT BY DIFFERENTIALLY MODULATING HIGH-AFFINITY IL-12 RECEPTOR EXPRESSION AND IL-12-INDUCED ACTIVATION OF STAT1 AND STAT5

      Blood
    83. MAHAJAN S; RUDDERS SA; RITZ J; FRANK DA
      LYMPHOCYTES FROM PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA CONTAIN STAT1 AND STAT3 CONSTITUTIVELY PHOSPHORYLATED ON SERINE

      Blood
    84. SOIFFER RJ; COLLINS H; RITZ J
      DEFECTIVE GD3 GANGLIOSIDE (CDW60) MEDIATED T-CELL RESPONSE FOLLOWING T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    85. WEBB IJ; SOIFFER RJ; ANDERSEN JW; COHEN CA; FREEMAN A; SUGRUE M; RITZ J; ANDERSON KC
      FFP TO ADSORB ISOHEMAGGLUTININS PRIOR TO MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION

      Blood
    86. ALYEA EP; CANNING C; COLLINS H; PICKETT C; WANG Y; SOIFFER RJ; RITZ J
      EFFICACY AND TOXICITY OF CD4-LYMPHOCYTE INFUSION FOR TREATMENT OF RELAPSED CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER ALLOGENEIC BMT( DONOR T)

      Blood
    87. BARTLETTPANDITE L; GRIBBEN JG; SOIFFER R; ANDERSEN NS; ANDERSON K; FISHER DC; FREEDMAN AS; RITZ J; NEUBERG D; NADLER LM
      POTENTIAL FOR CURE OF B-CELL CLL AND SLL - PROLONGED DISEASE-FREE SURVIVAL AND MOLECULAR REMISSIONS FOLLOWING AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    88. SOIFFER RJ; NEUBERG D; FREEDMAN AS; ALYEA EP; FISHER DC; BARTLETTPANDITE L; GRIBBEN J; SCHLOSSMAN RL; FREEMAN A; ANDERSON KC; NADLER LM; RITZ J
      CD6 DEPLETED ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR NON-HODGKINS-LYMPHOMA

      Blood
    89. SCHUMANN RR; NAKARAI T; GRUSS HJ; BRACH MA; VONARNIM U; KIRSCHNING C; KARAWAJEW L; LUDWIG WD; RENAULD JC; RITZ J; HERRMANN F
      TRANSCRIPT SYNTHESIS AND SURFACE EXPRESSION OF THE INTERLEUKIN-2 RECEPTOR (ALPHA-CHAIN, BETA-CHAIN, AND GAMMA-CHAIN) BY NORMAL AND MALIGNANT MYELOID CELLS

      Blood
    90. NGUYEN PL; HARRIS NL; RITZ J; ROBERTSON MJ
      EXPRESSION OF CD95 ANTIGEN AND BCL-2 PROTEIN IN NON-HODGKINS-LYMPHOMAS AND HODGKINS-DISEASE

      The American journal of pathology
    91. WANG DK; RITZ J; ROBERTSON MJ
      CHARACTERIZATION OF CD95 MONOCLONAL-ANTIBODIES - EPITOPE SPECIFICITIES AND FUNCTIONAL-EFFECTS

      Tissue antigens
    92. WANG DK; RITZ J; ROBERTSON MJ
      EXPRESSION OF TNF RECEPTOR SUPERFAMILY MEMBERS AND IL-1 RECEPTORS BY NATURAL-KILLER-CELLS

      Tissue antigens
    93. ROBERTSON MJ; MANLEY TJ; PICHERT G; CAMERON C; COCHRAN KJ; LEVINE H; RITZ J
      FUNCTIONAL CONSEQUENCES OF APO-1 FAS (CD95) ANTIGEN EXPRESSION BY NORMAL AND NEOPLASTIC HEMATOPOIETIC-CELLS/

      Leukemia & lymphoma
    94. SEIDEN MV; SCHLOSSMAN R; ANDERSEN J; FREEMAN A; ROBERTSON M; SOIFFER R; FREEDMAN A; MAUCH P; RITZ J; NADLER L; ANDERSON KC
      MONOCLONAL ANTIBODY-PURGED BONE-MARROW TRANSPLANTATION THERAPY FOR MULTIPLE-MYELOMA

      Leukemia & lymphoma
    95. SOIFFER RJ; ALYEA EP; RITZ J
      IMMUNOMODULATORY EFFECTS OF DONOR LYMPHOCYTE INFUSIONS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Journal of clinical apheresis
    96. PICHERT G; ROY DC; GONIN R; ALYEA EP; BELANGER R; GYGER M; PERREAULT C; BONNY Y; LERRA I; MURRAY C; SOIFFER RJ; RITZ J
      DISTINCT PATTERNS OF MINIMAL RESIDUAL DISEASE-ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA

      Journal of clinical oncology
    97. LEW MA; KEHOE K; RITZ J; ANTMAN KH; NADLER L; KALISH LA; FINBERG R
      CIPROFLOXACIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PROPHYLAXIS OFBACTERIAL-INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS - A RANDOMIZED, CONTROLLED TRIAL

      Journal of clinical oncology
    98. ROY DC; PERREAULT C; BELANGER R; GYGER M; LEHOUILLIER C; BLATTLER WA; LAMBERT JM; RITZ J
      ELIMINATION OF B-LINEAGE LEUKEMIA AND LYMPHOMA-CELLS FROM BONE-MARROWGRAFTS USING ANTI-B4-BLOCKED-RICIN IMMUNOTOXIN

      Journal of clinical immunology
    99. FRANK DA; ROBERTSON MJ; BONNI A; RITZ J; GREENBERG ME
      INTERLEUKIN-2 SIGNALING INVOLVES THE PHOSPHORYLATION OF STAT PROTEINS

      Proceedings of the National Academy of Sciences of the United Statesof America
    100. NGUYEN PL; ROBERTSON MJ; RITZ J; HARRIS NL
      EXPRESSION OF CD95 AND BCL-2 PROTEINS IN LOW-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS

      Laboratory investigation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 03:27:28